A team of Notre Dame researchers from NDnano, AD&T, and Harper Cancer Research Institute have started to investigate the use of magnetoelectric nanoparticles (MENs) as carrier vehicles for targeted drug delivery in cancer treatment. 

The MENs work, led by Dr. Tiffanie Stewart, builds on research published this year by her alma mater, Florida International University (Scientific Reports, 6:20867, DOI: 101038/srep20867) that demonstrates that specially designed and fabricated MENs can be directed throughout the body by external magnets and manipulated to selectively penetrate diseased tumor cells before releasing their drugs.

The short video below explains the science behind the MENs drug delivery platform.